Spectral Med Inc faced a significant decline in stock value, raising concerns among investors.
Spectral Med Inc (EDT.TO) saw its stock price drop by 5.53% in yesterday's trading session, closing at CA$1.11. This decline is notable given the company's recent announcements and market cap of approximately CA$325 million.
Advertisement
Spectral Med Inc
EDT.TO
EDT.TO
Spectral Med Inc
WealthAwesomeMarket cap
$325.84M
52W high
$1.65
52W low
$1.03
1W change
-5.13%
Beta
0.22
Analyst Price Targets
Based on analyst covering EDT · as of Sep 17, 2026
Wall Street analysts forecast EDT stock price to rise 183.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.15
+183.8% Upside
Current Price
C$1.11
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EDT's historical volatility
30-Day Vol
40.5%
Annualized
90-Day Vol
32.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.93
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.05 | C$0.91 – C$1.20 |
| 60 trading days | C$0.99 | C$0.81 – C$1.20 |
| 90 trading days | C$0.93 | C$0.73 – C$1.18 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should be cautious about the volatility in Spectral Med's stock, especially in light of its recent performance and lack of significant news.
5.53% Drop in Stock Value
Spectral Med's stock fell significantly yesterday, reflecting investor concerns amid a challenging market environment.
Bull case
Despite the recent downturn, Spectral Med has reported positive results from its Tigris trial. If the company can successfully navigate its regulatory pathways, these results could set the stage for future growth.
Bear case
The stock's decline may signal deeper issues, such as skepticism about the company's future or broader market trends that are affecting investor sentiment.
Market Reaction
Advertisement
The 5.53% drop in Spectral Med's stock price yesterday reflects a broader trend of uncertainty in the market. Investors may be reacting to the lack of recent news that could boost confidence in the company's future performance. With no significant announcements since the Tigris trial results, the stock's movement could indicate a wait-and-see approach among shareholders.
Company Fundamentals
Spectral Med Inc has a market cap of CA$325 million, but its P/E ratio is not applicable and there is no dividend yield. These financial metrics may raise red flags for potential investors. The absence of profit margins complicates the investment landscape, suggesting that while the company is engaged in promising medical research, it has yet to turn that into financial success.
Looking Ahead
As investors assess the implications of yesterday's decline, they will be closely monitoring any developments from Spectral Med, particularly regarding its PMA submission for PMX-20R and further updates on the Tigris trial. The company's ability to communicate progress and manage investor expectations will be crucial in regaining market confidence.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
